Is the FDA doing its best to put CBD into the pockets of Big Food and Big Pharma?

Why would the FDA warn consumers against CBD? They don’t issue alerts about ingesting food with residues of glyphosate in it. They don’t warn about the excitotoxic amino acids in the low-calorie sweetener know as aspartame, Equal, or AminoSweet. They don’t even tell the consumer that “diet sodas” actually prevent weight loss. And for sure they don’t tell consumers about the excitotoxic amino acids in monosodium glutamate (MSG), hydrolyzed protein, and protein powders that cause brain damage, endocrine disorders, and reactions such as a-fib, asthma, migraine headache, and seizures.

Many years ago, I set out to uncover what was causing my husband to go into anaphylactic shock. We knew that monosodium glutamate was a trigger, but he’d have reactions at times when there was no monosodium glutamate in anything he had consumed. I read everything I could get my hands on, and along the way I realized that there were two kinds of information circulating about the safety of MSG — one published by independent scientists who found MSG to have toxic potential and another published by the people who manufacture MSG.

Another interesting discovery I made was that the FDA wasn’t looking out for the welfare of the individual consumer. The FDA was looking out for the welfare of people who worked at the FDA — those who looked out for Big Food and Big Pharma while they were at the FDA and took cushy jobs with Big Food and Big Pharma (or their law firms or PR firms) upon leaving the agency. Or people like Michael Taylor who moved between formal employment with Monsanto and the USDA, and Monsanto and the FDA, all the while guaranteeing that things like aspartame and bST were approved, directly or indirectly, for use in food.

My take on the FDA’s CBD warnings is that it has to do with Big Pharma’s long-term program for reaping great profits from CBD — starting with FDA approval of the obscenely priced drug Epidiolex, recently OK’d for childhood seizures. But for that to be successful, Big Pharma also has to obliterate its competition. Warning consumers about CBD is just the start of FDA attacks on CBD products that don’t put money into the pockets of Big Pharma and Big Food.

Adrienne Samuels

If you have questions or comments, we’d love to hear from you. If you have hints for others on how to avoid exposure to MfG, send them along, too, and we’ll put them up on Facebook. Or you can reach us at questionsaboutmsg@gmail.com and follow us on Twitter @truthlabeling.

2 Replies to “Is the FDA doing its best to put CBD into the pockets of Big Food and Big Pharma?”

  1. It is crazy to think that the FDA would have the interests of big companies rather than the people. But after reading this article, I actually took some time to think about it.

    If Big Pharma and Big Food have millions, if not, billions of dollars to lobby the government, then it isn’t far-fetched to think that FDA would do things that benefit those companies.

    Makes sense why the country is going through a pain medication crisis right now. Big Pharma wants people to be dependent on their products so much so that nothing else works for them.

    CBD is the exact opposite of that. It isn’t addictive and so the long term value of people NEEDING to use it goes away.

Leave a Reply

Your email address will not be published. Required fields are marked *